loadpatents
Patent applications and USPTO patent grants for Hayashi; Tomoko.The latest application filed is for "n-aryl sulfonamide derivatives as vaccine adjuvant".
Patent | Date |
---|---|
N-aryl Sulfonamide Derivatives As Vaccine Adjuvant App 20220305121 - Carson; Dennis A. ;   et al. | 2022-09-29 |
Tlr4-tlr7 Ligand Formulations As Vaccine Adjuvants App 20220152188 - Carson; Dennis A. ;   et al. | 2022-05-19 |
Vaccine Adjuvant App 20210380546 - Carson; Dennis ;   et al. | 2021-12-09 |
Conjugation Of Tlr7 Agonist To Nano-materials Enhances The Agonistic Activity App 20210038742 - Huang; Ching-Hsin ;   et al. | 2021-02-11 |
Methods For Isolating, Expanding And Administering Cancer Specific Cd8+ T Cells App 20200087625 - Carson; Dennis A. ;   et al. | 2020-03-19 |
Method Of Treating Atherosclerosis In High Triglyceride Subjects App 20180153861 - ARAI; Yoshie ;   et al. | 2018-06-07 |
Synthetic Tlr4 And Tlr7 Ligands To Prevent, Inhibit Or Treat Liver Disease App 20180110784 - Carson; Dennis A. ;   et al. | 2018-04-26 |
Method of treating atherosclerosis in high triglyceride subjects Grant 9,867,811 - Arai , et al. January 16, 2 | 2018-01-16 |
Assembly method of an inline type fan motor Grant 9,748,814 - Ishihara , et al. August 29, 2 | 2017-08-29 |
Compositions and methods for modulating TLR4 Grant 9,505,768 - Carson , et al. November 29, 2 | 2016-11-29 |
Uses Of Phospholipid Conjugates Of Synthetic Tlr7 Agonists App 20160199499 - Carson; Dennis A. ;   et al. | 2016-07-14 |
Synthetic Tlr4 And Tlr7 Ligands As Vaccine Adjuvants App 20150366962 - Carson; Dennis A. ;   et al. | 2015-12-24 |
Compositions And Methods For Modulating Tlr4 App 20150197527 - Carson; Dennis A. ;   et al. | 2015-07-16 |
Novel Immune Activators: Substitute 4-aminoquinazolines App 20150132342 - Carson; Dennis A. ;   et al. | 2015-05-14 |
Fan Motor, Inline Type Fan Motor And Assembly Method App 20140354117 - Ishihara; Katsumichi ;   et al. | 2014-12-04 |
Toll-like receptor modulators and treatment of diseases Grant 8,729,088 - Carson , et al. May 20, 2 | 2014-05-20 |
Method Of Treating Atherosclerosis In High Triglyceride Subjects App 20140134262 - Arai; Yoshie ;   et al. | 2014-05-15 |
Uses Of Phospholipid Conjugates Of Synthetic Tlr7 Agonists App 20130202629 - Carson; Dennis A. ;   et al. | 2013-08-08 |
Toll-like Receptor Modulators And Treatment Of Diseases App 20100210598 - Carson; Dennis A. ;   et al. | 2010-08-19 |
1,3,5-tris (arylamino) benzenes Grant 7,271,291 - Inada , et al. September 18, 2 | 2007-09-18 |
1,3,5-tris(arylamino)benzenes Grant 7,196,224 - Akashi , et al. March 27, 2 | 2007-03-27 |
Novel 1, 3, 5 tris (arylamino) benzenes App 20060173216 - Inada; Hiroshi ;   et al. | 2006-08-03 |
Novel 1,3,5-tris(arylamino)benzene App 20050090692 - Akashi, Nobutaka ;   et al. | 2005-04-28 |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen App 20030212028 - Raz, Eyal ;   et al. | 2003-11-13 |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen Grant 6,552,006 - Raz , et al. April 22, 2 | 2003-04-22 |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen App 20020086295 - Raz, Eyal ;   et al. | 2002-07-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.